Allergan PLC, formerly Actavis plc, is a specialty pharmaceutical company engaged in the development, manufacturing, marketing, and distribution of generic, branded generic, brand name, biosimilar and over-the-counter (OTC) pharmaceutical products. It also develops and out-licenses generic pharmaceutical products primarily in Europe through its Medis third-party business. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment includes patent-protected and off-patent products marketed within North America. The North American Generics and International segment includes trademarked off-patent products, and brand pharmaceutical patent-protected and off-patent products, certain trademarked off-patent products, OTC products, and revenues from its third party Medis business. The Anda Distribution segment distributes generic and brand pharmaceutical products manufactured by third parties.